| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.15 | 0.0007 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |